Add Company
Join Now

Avelas Biosciences Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Avelas Biosciences's estimated annual revenue is currently $1.1M per year.(i)
  • Avelas Biosciences's estimated revenue per employee is $155,000

Employee Data

  • Avelas Biosciences has 7 Employees.(i)
  • Avelas Biosciences grew their employee count by -42% last year.

Avelas Biosciences's People

NameTitleEmail/Phone
1
Exec. Director, Clinical OperationsReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
President and CEOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Avelas Biosciences?

Avelas Biosciences is a clinical-stage biotechnology company and a pioneer in the field of intraoperative fluorescent cancer imaging. The company is focused on developing pegloprastide (also known as AVB-620), a novel drug-device combination product for use during cancer surgery. Pegloprastide is designed to improve surgery by detecting cancer in real time and has the potential to become part of standard-of-care treatment for a variety of cancer surgeries.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$1.1M

Revenue (est)

-42%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.1M717%N/A
#2
$0.5M7-12%N/A
#3
$0.6M7N/AN/A
#4
$1.1M7-30%N/A
#5
$0.6M717%N/A